Nkarta Inc (NKTX)
2.45
+0.01
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
2.48
+0.03
(+1.22%)
After-Hours: 20:00
Nkarta Total Assets (Quarterly): 532.03M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 532.03M |
June 30, 2024 | 554.09M |
March 31, 2024 | 576.94M |
December 31, 2023 | 378.88M |
September 30, 2023 | 405.86M |
June 30, 2023 | 429.04M |
March 31, 2023 | 458.17M |
December 31, 2022 | 472.94M |
September 30, 2022 | 503.80M |
June 30, 2022 | 503.64M |
Date | Value |
---|---|
March 31, 2022 | 306.30M |
December 31, 2021 | 273.90M |
September 30, 2021 | 292.46M |
June 30, 2021 | 309.11M |
March 31, 2021 | 325.69M |
December 31, 2020 | 337.65M |
September 30, 2020 | 352.30M |
June 30, 2020 | 43.62M |
March 31, 2020 | 41.12M |
December 31, 2019 | 48.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
41.12M
Minimum
Mar 2020
576.94M
Maximum
Mar 2024
357.30M
Average
365.59M
Median
Total Assets (Quarterly) Benchmarks
AMN Healthcare Services Inc | 2.668B |
Moderna Inc | 15.80B |
CEL-SCI Corp | 24.07M |
AIM ImmunoTech Inc | 13.59M |
IGC Pharma Inc | 10.37M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 101.16M |
Shareholders Equity (Quarterly) | 430.87M |